4.3 VF and Pulseless VT Algorithm
Key Takeaways
- The VF/pVT loop is CPR for 2 minutes, rhythm check, shock if still shockable, resume CPR immediately — repeating until ROSC or termination.
- Defibrillate as soon as VF/pVT is identified: biphasic 120-200 J device-specific (or max if unknown), monophasic 360 J, with subsequent shocks equal or higher.
- Epinephrine 1 mg IV/IO is given every 3-5 minutes, typically starting after the second shock in the shockable pathway.
- Amiodarone 300 mg IV/IO is the first antiarrhythmic (after the third shock), followed by 150 mg; lidocaine 1-1.5 mg/kg then 0.5-0.75 mg/kg is the alternative.
- Drugs supplement but never replace high-quality CPR and early defibrillation; resume compressions instantly after every shock without a pulse check.
4.3 VF and Pulseless VT Algorithm
Ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT) are the shockable arrest rhythms, and their algorithm is the most heavily tested ACLS pathway. The single most powerful intervention is early defibrillation layered on top of high-quality CPR; every other step — drugs, airway, reversible-cause search — supports those two.
The loop, step by step
The algorithm is a repeating 2-minute cycle:
- Identify VF/pVT on the monitor.
- Deliver one shock as soon as the team is clear. Resume compressions the instant the shock fires — do not pause to check a pulse.
- CPR for 2 minutes (about 5 cycles of 30:2, or continuous compressions with an advanced airway). During this time, establish IV/IO access.
- Rhythm check (about 10 seconds). If still VF/pVT, shock again.
- After the second shock, give epinephrine 1 mg IV/IO, then repeat every 3-5 minutes.
- After the third shock, give the first antiarrhythmic — amiodarone 300 mg IV/IO (or lidocaine).
- Continue the loop, adding the second antiarrhythmic dose and continuing epinephrine on schedule, while searching the H's and T's.
- Exit on ROSC (organized rhythm + pulse, or a sudden ETCO2 rise) to post-arrest care, or convert to the PEA/asystole pathway if the rhythm becomes nonshockable.
Defibrillation energy
| Defibrillator type | First shock | Subsequent shocks |
|---|---|---|
| Biphasic | Manufacturer-recommended 120-200 J (use 200 J if the effective range is unknown) | Equivalent or higher energy |
| Monophasic | 360 J | 360 J |
Biphasic waveforms terminate fibrillation at lower energy with less myocardial damage, which is why nearly all modern devices are biphasic. Pad position (anterolateral or anteroposterior), good skin contact, and clearing the patient all matter for an effective shock.
ACLS drug doses for VF/pVT
| Drug | Dose | Timing / notes |
|---|---|---|
| Epinephrine | 1 mg IV/IO, repeat every 3-5 minutes | Start after the 2nd shock; follow each push with a 20 mL saline flush and raise the limb. |
| Amiodarone | 300 mg IV/IO first dose, then 150 mg | First antiarrhythmic, given after the 3rd shock; maximum ~2.2 g/24 h. |
| Lidocaine | 1-1.5 mg/kg first dose, then 0.5-0.75 mg/kg | Alternative to amiodarone; may repeat to a max of 3 mg/kg. |
Note that amiodarone and lidocaine are alternatives, not given together; the team picks one antiarrhythmic for refractory VF/pVT.
How this is tested and common traps
Exam stems typically place you at a specific point in the loop ("after the second shock, what drug?" or "the rhythm is still VF after three shocks and epinephrine — what next?"). Anchor your answers to the sequence: shock → CPR → epinephrine after shock 2 → amiodarone after shock 3 → repeat.
Common traps:
- Pausing for a pulse check immediately after a shock. You resume CPR instead; reassess at the next rhythm check.
- Giving an antiarrhythmic before any shock or epinephrine. Amiodarone/lidocaine are for refractory VF/pVT, after early shocks and epinephrine.
- Stacking shocks without intervening CPR (an outdated practice — single-shock strategy is current).
- Combining amiodarone and lidocaine — choose one.
- Forgetting the basics in refractory VF: check pad position/contact, compressor fatigue (swap every 2 minutes), and the H's and T's.
The governing principle: drugs and airway are adjuncts. If a choice would delay a shock or interrupt compressions, it is almost certainly the distractor.
A full two-cycle walkthrough
Tracing the algorithm minute by minute cements the sequence and the drug timing:
| Time | Event | Drug given |
|---|---|---|
| 0:00 | VF identified → Shock 1 → resume CPR | — |
| 0:00-2:00 | CPR; establish IV/IO access | — |
| 2:00 | Rhythm check: still VF → Shock 2 → resume CPR | Epinephrine 1 mg |
| 2:00-4:00 | CPR; consider advanced airway | — |
| 4:00 | Rhythm check: still VF → Shock 3 → resume CPR | Amiodarone 300 mg |
| 4:00-6:00 | CPR; work the H's and T's | — |
| 6:00 | Rhythm check: still VF → Shock 4 → resume CPR | Epinephrine 1 mg (next interval) |
| 6:00-8:00 | CPR | — |
| 8:00 | Rhythm check: still VF → Shock 5 → resume CPR | Amiodarone 150 mg |
Notice that epinephrine repeats on its own 3-5 minute clock (here roughly every other cycle) while amiodarone is a one-time 300 mg then 150 mg sequence. Real timing is approximate because rhythm checks happen on the 2-minute boundary.
Single-shock strategy and CPR fraction
Current AHA practice uses a single-shock strategy — one shock, then immediate CPR — rather than the older stacked three-shock sequence, because resuming compressions quickly preserves coronary perfusion pressure. Teams should also protect a high chest-compression fraction (CCF), ideally at least 60-80% of code time spent actively compressing. Charging the defibrillator during compressions and pre-assigning the post-shock compressor are concrete ways to keep pauses near 5 seconds and the CCF high.
Refractory VF that persists after several shocks should prompt a deliberate re-check of pad position (consider switching to anteroposterior), pad-skin contact, compressor fatigue, and the reversible H's and T's — not simply more of the same.
During a resuscitation, epinephrine 1 mg IV is given for VF. When should the NEXT dose be administered?
In refractory VF, the first antiarrhythmic is amiodarone. What are the correct first and second doses?
A patient with confirmed pulmonary embolism is in pulseless cardiac arrest. What additional intervention should be STRONGLY considered?